2015
Tissue-type plasminogen activator (tPA) is the only acute treatment for ischemic stroke. Unfortunately, the benefit of tPA-driven thrombolysis is not (…)
Consulter 
2015
Numerous treatments have been reported to provide a beneficial outcome in experimental animal stroke models; however, these treatments (with the (…)
Consulter
2015
Endothelial activation is a hallmark of cardiovascular diseases, acting either as a cause or a consequence of organ injury. To (…)
Consulter
2015
Tissue-type plasminogen activator (tPA) is a pleiotropic serine protease of the central nervous system (CNS) with reported neurotrophic and neurotoxic (…)
Consulter
2016
Reverse transcription quantitative-polymerase chain reaction (RT-qPCR) has become a routine method in many laboratories. Normalization of data from experimental conditions (…)
Consulter
2016
In the central nervous system, tissue-type plasminogen activator (tPA) has been associated with both pro-death and prosurvival actions on neurons. (…)
Consulter
